Señales en vivo de 603520.SS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 abr 2024 @ 23:30):

Stats
Volumen de hoy	3.88M
Volumen promedio	7.88M
Capitalización de mercado	4.23B
EPS	CNY0 ( 2023-10-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-72.71
ATR14	CNY0.0200 (0.16%)

Volumen Correlación

Largo: -0.08 (neutral)

Corto: -0.68 (moderate negative)

Signal:(33.122) Neutral

Zhejiang Starry Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Zhejiang Starry Correlación - Moneda/Commodity

-0.41
( neutral )

-0.38
( neutral )

0.00
( neutral )

-0.64
( weak negative )

0.31
( neutral )

-0.51
( weak negative )

Zhejiang Starry Finanzas

Annual	2022
Ingresos:	CNY2.13B
Beneficio Bruto:	CNY512.45M (24.04 %)
EPS:	CNY-0.210

FY	2022
Ingresos:	CNY2.13B
Beneficio Bruto:	CNY512.45M (24.04 %)
EPS:	CNY-0.210

FY	2021
Ingresos:	CNY2.00B
Beneficio Bruto:	CNY747.98M (37.40 %)
EPS:	CNY1.320

FY	2020
Ingresos:	CNY1.37B
Beneficio Bruto:	CNY601.36M (43.99 %)
EPS:	CNY1.000

Financial Reports:

No articles found.

Zhejiang Starry

Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones products comprise levofloxacin, levofloxacin hydrochloride, levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate. The company was founded in 1997 and is based in Xianju, China.